MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, EDIT has $149,338K in assets. $144,930K in debts. $123,648K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
321.94%
Quick Ratio
321.94%
Cash Ratio
310.84%
Debt to Asset Ratio
97.05%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Right-of-use assets
    • Restricted cash and other non-cu...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Liability for sale of future rev...
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Marketable securities
-0 0 39,959
Cash and cash equivalents
123,648 146,645 165,648 138,542
Accounts receivable
2,592 15,176 8,130 588
Prepaid expenses and other current assets
1,826 2,074 3,113 3,707
Total current assets
128,066 163,895 176,891 182,796
Property and equipment, net
2,884 3,542 4,287 4,576
Right-of-use assets
15,412 16,121 17,583 19,011
Restricted cash and other non-current assets
2,976 2,976 2,990 4,198
Total assets
149,338 186,534 201,751 210,581
Deferred revenue, current
-0 0 0
Accounts payable
4,332 2,605 3,163 6,723
Accrued expenses
21,248 32,610 47,522 48,068
Liability for sale of future revenues, current
7,500 5,000 5,000 5,000
Operating lease liabilities, current
6,699 6,031 6,088 6,146
Total current liabilities
39,779 46,246 61,773 65,937
Operating lease liabilities, net of current portion
10,598 12,071 13,564 14,989
Liability for sale of future revenues, net of current portion
47,177 53,605 54,069 51,670
Deferred revenue, net of current portion
44,509 44,509 54,204 54,204
Other non-current liabilities
2,867 2,815 4,688 4,592
Total liabilities
144,930 159,246 188,298 191,392
Common stock, 0.0001 par value per share 390,000,000 shares authorized 97,901,034 and 97,866,996 shares issued and outstanding at march31, 2026 and december31, 2025, respectively
10 10 9 9
Additional paid-in capital
1,657,883 1,655,781 1,636,327 1,616,931
Accumulated other comprehensive income
0 0 0 15
Accumulated deficit
-1,653,485 -1,628,503 -1,622,883 -1,597,766
Total stockholders equity
4,408 27,288 13,453 19,189
Total liabilities and stockholders equity
149,338 186,534 201,751 210,581
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$123,648K Accounts receivable$2,592K Prepaid expenses andother current assets$1,826K Total current assets$128,066K Right-of-use assets$15,412K Restricted cash and othernon-current assets$2,976K Property and equipment,net$2,884K Total assets$149,338K Total liabilities andstockholders equity$149,338K Total liabilities$144,930K Total stockholdersequity$4,408K Accumulated deficit-$1,653,485K Liability for sale offuture revenues, net of...$47,177K Deferred revenue, net ofcurrent portion$44,509K Total currentliabilities$39,779K Operating leaseliabilities, net of current...$10,598K Other non-currentliabilities$2,867K Additional paid-in capital$1,657,883K Common stock, 0.0001par value per share...$10K Accrued expenses$21,248K Liability for sale offuture revenues,...$7,500K Operating leaseliabilities, current$6,699K Accounts payable$4,332K

Editas Medicine, Inc. (EDIT)

Editas Medicine, Inc. (EDIT)